Corrigendum to “CD133-targeted Gene Transfer Into Long-term Repopulating Hematopoietic Stem Cells” (Molecular Therapy (2015) 23(1) (63–70)(S1525001616300119)(10.1038/mt.2014.173));CD133-targeted gene transfer into long-term repopulating hematopoietic stem cells

Molecular Therapy

Volumn 23, Issue 1, 2015, Pages 63-70

  Brendel, Christian ^a,f   Goebel, Benjamin ^b   Daniela, Abriss ^a   Brugman, Martijn ^c   Kneissl, Sabrina ^d   Schwäble, Joachim ^b   Kaufmann, Kerstin B ^a   Müller Kuller, Uta ^a   Kunkel, Hana ^a   Chen Wichmann, Linping ^a,g   Abel, Tobias ^d   Serve, Hubert ^b   Bystrykh, Leonid ^e   Buchholz, Christian J ^d   Grez, Manuel ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d PAUL EHRLICH INSTITUT   (Germany)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; G ENVELOPE PROTEIN; GENE THERAPY AGENT; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG; G PROTEIN, VESICULAR STOMATITIS VIRUS; GLYCOPROTEIN; GREEN FLUORESCENT PROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PEPTIDE; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; ENGRAFTMENT; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PSEUDOTYPING; VESICULOVIRUS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; X LINKED CHRONIC GRANULOMATOUS DISEASE; ANIMAL; CYTOLOGY; GENE EXPRESSION; GENE THERAPY; GENE VECTOR; GENETICS; GRANULOMATOUS DISEASE, CHRONIC; IMMUNOLOGY; LENTIVIRINAE; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PRIMARY CELL CULTURE; PROCEDURES; VESICULAR STOMATITIS INDIANA VIRUS;

MUS; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; GLYCOPROTEINS; GRANULOMATOUS DISEASE, CHRONIC; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; LENTIVIRUS; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MICE; PEPTIDES; PRIMARY CELL CULTURE; TRANSDUCTION, GENETIC; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 84920553698     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2015.26     Document Type: Erratum

References (51)

1. Aiuti, A, Biasco, L, Scaramuzza, S, Ferrua, F, Cicalese, M P, Baricordi, C et al. (2013). Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341: 1233151.
2. Cartier, N, Hacein-Bey-Abina, S, Bartholomae, CC, Veres, G, Schmidt, M, Kutschera, I et al. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science (New York, N.Y.) 326: 818-823.
3. Biff, A, Montini, E, Lorioli, L, Cesani, M, Fumagalli, F, Plati, T et al. (2013). Lentiviral hematopoietic stem cell gene therapy benefts metachromatic leukodystrophy. Science 341: 1233158.
4. Kaufmann, KB, Büning, H, Galy, A, Schambach, A and Grez, M (2013). Gene therapy on the move. EMBO Mol Med 5: 1642-1661.
5. Seymour, LW and Thrasher, AJ (2012). Gene therapy matures in the clinic. Nat Biotechnol 30: 588-593.
6. Kim, S, Kim, N, Presson, AP, Metzger, ME, Bonifacino, AC, Sehl, M et al. (2014). Dynamics of HSPC repopulation in nonhuman primates revealed by a decade-long clonal-tracking study. Cell Stem Cell 14: 473-485.
7. Bhatia, M, Wang, JC, Kapp, U, Bonnet, D and Dick, JE (1997). Purifcation of primitive human hematopoietic cells capable of repopulating immune-defcient mice. Proc Natl Acad Sci USA 94: 5320-5325.
8. Guenechea, G, Gan, OI, Dorrell, C and Dick, JE (2001). Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2: 75-82.
9. McKenzie, JL, Gan, OI, Doedens, M, Wang, JC and Dick, JE (2006). Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nat Immunol 7: 1225-1233.
10. Lapidot, T, Pfumio, F, Doedens, M, Murdoch, B, Williams, DE and Dick, JE (1992). Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255: 1137-1141.
11. Vormoor, J, Lapidot, T, Pfumio, F, Risdon, G, Patterson, B, Broxmeyer, HE et al. (1994). Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodefcient mice. Blood 83: 2489-2497.
12. Notta, F, Doulatov, S, Laurenti, E, Poeppl, A, Jurisica, I and Dick, JE (2011). Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333: 218-221.
13. Yin, AH, Miraglia, S, Zanjani, ED, Almeida-Porada, G, Ogawa, M, Leary, AG et al. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012.
14. Miraglia, S, Godfrey, W, Yin, AH, Atkins, K, Warnke, R, Holden, JT et al. (1997). A novel fve-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021.
15. Freund, D, Oswald, J, Feldmann, S, Ehninger, G, Corbeil, D and Bornhäuser, M (2006). Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor. Cell Prolif 39: 325-332.
16. Summers, YJ, Heyworth, CM, de Wynter, EA, Hart, CA, Chang, J and Testa, NG (2004). AC133+ G0 cells from cord blood show a high incidence of long-term culture-initiating cells and a capacity for more than 100 million-fold amplifcation of colony-forming cells in vitro. Stem Cells 22: 704-715.
17. Gordon, PR, Leimig, T, Babarin-Dorner, A, Houston, J, Holladay, M, Mueller, I et al. (2003). Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells. Bone Marrow Transplant 31: 17-22.
18. Tura, O, Barclay, GR, Roddie, H, Davies, J and Turner, ML (2007). Absence of a relationship between immunophenotypic and colony enumeration analysis of endothelial progenitor cells in clinical haematopoietic cell sources. J Transl Med 5: 37.
19. Lang, P, Bader, P, Schumm, M, Feuchtinger, T, Einsele, H, Führer, M et al. (2004). Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. Br J Haematol 124: 72-79.
20. Géronimi, F, Richard, E, Redonnet-Vernhet, I, Lamrissi-Garcia, I, Lalanne, M, Ged, C et al. (2003). Highly effcient lentiviral gene transfer in CD34+ and CD34+/38-/lin-cells from mobilized peripheral blood after cytokine prestimulation. Stem Cells 21: 472-480.
21. Catlin, SN, Busque, L, Gale, RE, Guttorp, P and Abkowitz, JL (2011). The replication rate of human hematopoietic stem cells in vivo. Blood 117: 4460-4466.
22. Finkelshtein, D, Werman, A, Novick, D, Barak, S and Rubinstein, M (2013). LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc Natl Acad Sci USA 110: 7306-7311.
23. Yanagi, Y, Takeda, M, Ohno, S and Hashiguchi, T (2009). Measles virus receptors. Curr Top Microbiol Immunol 329: 13-30.
24. Mühlebach, MD, Mateo, M, Sinn, PL, Prüfer, S, Uhlig, KM, Leonard, VH et al. (2011). Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480: 530-533.
25. Anliker, B, Abel, T, Kneissl, S, Hlavaty, J, Caputi, A, Brynza, J et al. (2010). Specifc gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nat Methods 7: 929-935.
26. Buchholz, CJ, Mühlebach, MD and Cichutek, K (2009). Lentiviral vectors with measles virus glycoproteins-dream team for gene transfer? Trends Biotechnol 27: 259-265.
27. Ailles, L, Schmidt, M, Santoni de Sio, FR, Glimm, H, Cavalieri, S, Bruno, S et al. (2002). Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells. Mol Ther 6: 615-626.
28. Amsellem, S, Ravet, E, Fichelson, S, Pfumio, F and Dubart-Kupperschmitt, A (2002). Maximal lentivirus-mediated gene transfer and sustained transgene expression in human hematopoietic primitive cells and their progeny. Mol Ther 6: 673-677.
29. Miyoshi, H, Smith, KA, Mosier, DE, Verma, IM and Torbett, BE (1999). Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283: 682-686.
30. Sutton, RE, Reitsma, MJ, Uchida, N and Brown, PO (1999). Transduction of human progenitor hematopoietic stem cells by human immunodefciency virus type 1-based vectors is cell cycle dependent. J Virol 73: 3649-3660.
31. Zielske, SP and Gerson, SL (2003). Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells. Mol Ther 7: 325-333.
32. Amirache, F, Lévy, C, Costa, C, Mangeot, PE, Torbett, BE, Wang, CX et al. (2014). Mystery solved: VSV-G-LVs do not allow effcient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood 123: 1422-1424.
33. Glimm, H, Oh, IH and Eaves, CJ (2000). Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood 96: 4185-4193.
34. Kittler, EL, Peters, SO, Crittenden, RB, Debatis, ME, Ramshaw, HS, Stewart, FM et al. (1997). Cytokine-facilitated transduction leads to low-level engraftment in nonablated hosts. Blood 90: 865-872.
35. Gothot, A, van der Loo, JC, Clapp, DW and Srour, EF (1998). Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-defcient mice. Blood 92: 2641-2649.
36. Bell, AJ Jr, Fegen, D, Ward, M and Bank, A (2010). RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors. Exp Biol Med (Maywood) 235: 1269-1276.
37. Hanawa, H, Kelly, PF, Nathwani, AC, Persons, DA, Vandergriff, JA, Hargrove, P et al. (2002). Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther 5: 242-251.
38. Lindemann, D and Rethwilm, A (2011). Foamy virus biology and its application for vector development. Viruses 3: 561-585.
39. Verhoeyen, E, Wiznerowicz, M, Olivier, D, Izac, B, Trono, D, Dubart-Kupperschmitt, A et al. (2005). Novel lentiviral vectors displaying "early-acting cytokines" selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells. Blood 106: 3386-3395.
40. Frecha, C, Costa, C, Nègre, D, Amirache, F, Trono, D, Rio, P et al. (2012). A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice. Blood 119: 1139-1150.
41. Wagner, W, Ansorge, A, Wirkner, U, Eckstein, V, Schwager, C, Blake, J et al. (2004). Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis. Blood 104: 675-686.
42. Hess, DA, Wirthlin, L, Craft, TP, Herrbrich, PE, Hohm, SA, Lahey, R et al. (2006). Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107: 2162-2169.
43. Gallacher, L, Murdoch, B, Wu, DM, Karanu, FN, Keeney, M and Bhatia, M (2000). Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95: 2813-2820.
44. Münch, RC, Mühlebach, MD, Schaser, T, Kneissl, S, Jost, C, Plückthun, A et al. (2011). DARPins: an effcient targeting domain for lentiviral vectors. Mol Ther 19: 686-693.
45. Bauer, N, Wilsch-Bräuninger, M, Karbanová, J, Fonseca, AV, Strauss, D, Freund, D et al. (2011). Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles-a role of the endocytic-exocytic pathway. EMBO Mol Med 3: 398-409.
46. Meregalli, M, Farini, A, Belicchi, M and Torrente, Y (2010). CD133(+) cells isolated from various sources and their role in future clinical perspectives. Expert Opin Biol Ther 10: 1521-1528.
47. Tárnok, A, Ulrich, H and Bocsi, J (2010). Phenotypes of stem cells from diverse origin. Cytometry A 77: 6-10.
48. Grosse-Gehling, P, Fargeas, CA, Dittfeld, C, Garbe, Y, Alison, MR, Corbeil, D et al. (2013). CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol 229: 355-378.
49. Kneissl, S, Abel, T, Rasbach, A, Brynza, J, Schneider-Schaulies, J and Buchholz, CJ (2012). Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies. PLoS ONE 7: e46667.
50. Kweder, H, Ainouze, M, Cosby, SL, Muller, CP, Lévy, C, Verhoeyen, E et al. (2014). Mutations in the H, F, or M Proteins Can Facilitate Resistance of Measles Virus to Neutralizing Human Anti-MV Sera. Adv Virol 2014: 205617.
51. Lévy, C, Amirache, F, Costa, C, Frecha, C, Muller, C P, Kweder, H et al. (2012). Lentiviral vectors displaying modifed measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells. Mol Ther 20: 1699-1712.